A non-synonymous SNP in the NOS2 associated with septic shock in patients with sepsis in Chinese populations

Human Genetics

Volumn 132, Issue 3, 2013, Pages 337-346

  Wang, Zhifu ^a,b   Feng, Kai ^c   Yue, Maoxing ^c   Lu, Xiaoguang ^d   Zheng, Qihan ^e   Zhang, Hongxing ^b   Zhai, Yun ^b   Li, Peiyao ^b   Yu, Lixia ^b   Cai, Mi ^b   Zhang, Xiumei ^b   Kang, Xin ^d   Shi, Weihai ^e   Xia, Xia ^b   Chen, Xi ^b   Cao, Pengbo ^b   Li, Yuanfeng ^b   Chen, Huipeng ^f   Ling, Yan ^f   Li, Yuxia ^f   He, Fuchu ^a,b   Zhou, Gangqiao ^b   more..

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c 306 HOSPITAL OF PLA   (China)

^d DALIAN UNIVERSITY   (China)

^e Wujin Hospital Affiliated with Jiangsu University   (China)

^f BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, HUMAN;

ABDOMINAL INFECTION; ADULT; ALCOHOL CONSUMPTION; APACHE; ARTICLE; CASE CONTROL STUDY; CHEST INFECTION; CHINESE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFECTION COMPLICATION; INFECTION RISK; INJURY; LYMPHOID CELL LINE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; AGED; ASIAN; CHINA; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS;

MUS;

ADULT; AGED; APACHE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE II; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

MLCS; MLOWN;

EID: 84875606087     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-012-1253-4     Document Type: Article

References (43)

1. Annane D, Sanquer S, Sebille V, Faye A, Djuranovic D, Raphael JC, Gajdos P, Bellissant E (2000) Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet 355:1143-1148
2. Cheng B, Xie G, Yao S, Wu X, Guo Q, Gu M, Fang Q, Xu Q, Wang D, Jin Y, Yuan S, Wang J, Du Z, Sun Y, Fang X (2007) Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med 35:2538-2546
3. Cramer JP, Mockenhaupt FP, Ehrhardt S, Burkhardt J, Otchwemah RN, Dietz E, Gellert S, Bienzle U (2004) iNOS promoter variants and severe malaria in Ghanaian children. Trop Med Int Health 9:1074-1080
4. Curran-Everett D (2010) Explorations in statistics: power. Adv Physiol Educ 34:41-43
5. Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL, Szabo C (1998) Effect of l-buthionine-(S,R)-sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite- and endotoxic shock-induced vascular failure. Br J Pharmacol 123:525-537
6. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53:135-159
7. Esper AM, Martin GS (2009) Extending international sepsis epidemiology: the impact of organ dysfunction. Crit Care 13:120
8. Feihl F, Waeber B, Liaudet L (2001) Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol Ther 91:179-213
9. Fourrier F, Jallot A, Leclerc L, Jourdain M, Racadot A, Chagnon JL, Rime A, Chopin C (1994) Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock. Circ Shock 43:171-178
10. Fu L, Zhao Y, Lu J, Shi J, Li C, Liu H, Li Y (2009) Functional single nucleotide polymorphism-1026C/A of inducible nitric oxide synthase gene with increased YY1-binding affinity is associated with hypertension in a Chinese Han population. J Hypertens 27:991-1000
11. Fukuyama N, Takebayashi Y, Hida M, Ishida H, Ichimori K, Nakazawa H (1997) Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock. Free Radic Biol Med 22:771-774
12. Gabriel S, Ziaugra L, Tabbaa D (2009) SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet 60:2.12.1-2.12.18
13. Hobbs MR, Udhayakumar V, Levesque MC, Booth J, Roberts JM, Tkachuk AN, Pole A, Coon H, Kariuki S, Nahlen BL, Mwaikambo ED, Lal AL, Granger DL, Anstey NM, Weinberg JB (2002) A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 360:1468-1475
14. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC (1990) Loss of vascular responsiveness induced by endotoxin involves l-arginine pathway. Am J Physiol 259:H1038-H1043
15. Kelleher ZT, Potts EN, Brahmajothi MV, Foster MW, Auten RL, Foster WM, Marshall HE (2011) NOS2 regulation of LPS-induced airway inflammation via S-nitrosylation of NF-κB p65. Am J Physiol Lung Cell Mol Physiol 301:L327-L333
16. Khwannimit B, Bhurayanontachai R (2009) The epidemiology of, and risk factors for, mortality from severe sepsis and septic shock in a tertiary-care university hospital setting. Epidemiol Infect 137:1333-1341
17. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-829
18. Kun JF, Mordmuller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, Weinberg JB, Kremsner PG (2001) Nitric oxide synthase 2(Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis 184:330-336
19. Levesque MC, Hobbs MR, O'Loughlin CW, Chancellor JA, Chen Y, Tkachuk AN, Booth J, Patch KB, Allgood S, Pole AR, Fernandez CA, Mwaikambo ED, Mutabingwa TK, Fried M, Sorensen B, Duffy PE, Granger DL, Anstey NM, Weinberg JB (2010) Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes. Hum Genet 127:163-182
20. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31:1250-1256
21. Lowenstein CJ, Padalko E (2004) iNOS (NOS2) at a glance. J Cell Sci 117:2865-2867
22. Madach K, Aladzsity I, Szilagyi A, Fust G, Gal J, Penzes I, Prohaszka Z (2010) 4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study. Crit Care 14:R79
23. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23:1638-1652
24. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554
25. Matsuda N, Hattori Y (2007) Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res 43:117-137
26. Ming W, Peng W, Cai M, Ji G (2006) Investigation on epidemiology in 645 cases with sepsis in surgical intensive care unit. Chin Crit Care Med 18:74-77
27. Nava E, Palmer RM, Moncada S (1991) Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 338:1555-1557
28. Nin N, El-Assar M, Sanchez C, Ferruelo A, Sanchez-Ferrer A, Martinez-Caro L, Rojas Y, Paula M, Hurtado J, Esteban A, Lorente JA (2011) Vascular dysfunction in sepsis: effects of the peroxynitrite decomposition catalyst MnTMPyP. Shock 36:156-161
29. Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765-769
30. Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Looareesuwan S, Tokunaga K (2002) Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand. J Infect Dis 186:578-581
31. Okayama H, Saito M, Oue N, Weiss JM, Stauffer J, Takenoshita S, Wiltrout RH, Hussain SP, Harris CC (2012) NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression. Int J Cancer. doi: 10.1002/ijc.27644
32. Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315-424
33. Pance A, Chantome A, Reveneau S, Bentrari F, Jeannin JF (2002) A repressor in the proximal human inducible nitric oxide synthase promoter modulates transcriptional activation. FASEB J 16:631-633
34. Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H (2010) Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 23:75-93
35. Petros A, Bennett D, Vallance P (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557-1558
36. Pittner A, Nalos M, Asfar P, Yang Y, Ince C, Georgieff M, Bruckner UB, Radermacher P, Froba G (2003) Mechanisms of inducible nitric oxide synthase (iNOS) inhibition-related improvement of gut mucosal acidosis during hyperdynamic porcine endotoxemia. Intensive Care Med 29:312-316
37. Qidwai T, Jamal F (2010) Inducible nitric oxide synthase (iNOS) gene polymorphism and disease prevalence. Scand J Immunol 72:375-387
38. Shen J, Wang RT, Wang LW, Xu YC, Wang XR (2004) A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer. World J Gastroenterol 10:3278-3283
39. Thair SA, Walley KR, Nakada TA, McConechy MK, Boyd JH, Wellman H, Russell JA (2011) A single nucleotide polymorphism in NF-κB inducing kinase is associated with mortality in septic shock. J Immunol 186:2321-2328
40. Tsukahara Y, Morisaki T, Kojima M, Uchiyama A, Tanaka M (2001) iNOS expression by activated neutrophils from patients with sepsis. ANZ J Surg 71:15-20
41. Velez DR, Hulme WF, Myers JL, Weinberg JB, Levesque MC, Stryjewski ME, Abbate E, Estevan R, Patillo SG, Gilbert JR, Hamilton CD, Scott WK (2009) NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans. Hum Genet 126:643-653
42. Wong JM, Billiar TR (1995) Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. Adv Pharmacol 34:155-170
43. Wurfel MM (2008) Genetic insights into sepsis: what have we learned and how will it help? Curr Pharm Des 14:1900-1911